🟢 Axsome Therapeutics Inc is trading 7.1% up today after settling SUNOSI® patent litigation

Axsome Therapeutics Inc is trading 7.1% up at $238.00 in pre-market action after the company announced a significant legal development.

• The company announced on June 3 that it has resolved all patent litigation related to its product SUNOSI® (solriamfetol).
• The litigation stemmed from applications by other companies seeking to market a generic version of SUNOSI in the United States.
• This positive news provides a clear catalyst for the stock's rebound from its recent pullback.